Wellington Shields Capital Management, LLC Gilead Sciences, Inc. Transaction History
Wellington Shields Capital Management, LLC
- $537 Million
- Q1 2025
A detailed history of Wellington Shields Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wellington Shields Capital Management, LLC holds 860 shares of GILD stock, worth $92,192. This represents 0.02% of its overall portfolio holdings.
Number of Shares
860
Previous 234,507
99.63%
Holding current value
$92,192
Previous $21.7 Million
99.56%
% of portfolio
0.02%
Previous 1.76%
Shares
11 transactions
Others Institutions Holding GILD
# of Institutions
2,288Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$12.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.6 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.38 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.85 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.74 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $134B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...